UCSF

ZINC03830283

Substance Information

In ZINC since Heavy atoms Benign functionality
September 30th, 2005 27 Yes

Other Names:

dil

1-(2-(N-Benzylanilino)-1-(isobutoxymethyl)ethyl)-pyrrolidine monohydrochloride monohydrate; 1-Pyrrolideneethanamine, beta-((2-methylpropoxy)methyl)-N-phenyl-N-(phenylmethyl)-, monohydrochloride, monohydrate; 1-Pyrrolidineethanamine, beta-((2-methylpropoxy

1-Pyrrolidineethanamine, beta-((2-methylpropoxy)methyl)-N-phenyl-N-(phenylmethyl)-

1-Pyrrolidineethanamine, beta-((2-methylpropoxy)methyl)-N-phenyl-N-(phenylmethyl)-, monohydrochloride; 1-Pyrrolidineethanamine, beta-((2-methylpropoxy)methyl)-N-phenyl-N-(phenylmethyl)-,monohydrochloride; 1978CERM; BEPADIN; BEPRIDIL HYDROCHLORIDE; Bepridi

64706-54-3

64706-54-3; Bepadin (TN); Bepridil (INN); D07520

64706-54-3; Bepridil; C06847

68099-86-5 (mono-hydrochloride)

68099-86-5; Bepridil hydrochloride; Prestwick_697

74764-40-2 (mono-hydrochloride, mono-hydrate)

74764-40-2; Bepridil hydrochloride (USAN); Bepridil hydrochloride hydrate (JAN); D00631; Vascor (TN)

AB00053643

AC-16059

AC1L1DHI

Ambap64706-54-3

BCBcMAP01_000130

Bepadin

Bepadin (TN)

Bepadin; Bepridil

Bepricor

Bepridil

Bepridil (BAN

Bepridil (INN)

Bepridil Hydrochloride

Bepridil hydrochloride hydrate

bepridil hydrochloride monohydrate

beta-((2-Methylpropoxy)methyl)-N-phenyl-N-(phenylmethyl)-1-pyrrolidineethanamine

Bio1_000388

Bio1_000877

Bio1_001366

Bio2_000021

Bio2_000501

BPBio1_000545

BRD-A91008255-001-02-8

BSPBio_000495

BSPBio_001301

BSPBio_002334

C06847

CERM 1978

CERM-1978

CHEBI:3061

CHEBI:52714; CHEBI:3062

CHEMBL1008

CID2351

Cordium

D07520

DAP000525

DB01244

DivK1c_000110

HMS1361B03

HMS1791B03

HMS1989B03

HMS2089C05

HSCI1_000377

IDI1_000110

IDI1_033771

INN); Bepridil HCl (FDA

INN); Bepridil Hydrochloride (FDA

JAN

KBio1_000110

KBio2_000021

KBio2_002225

KBio2_002589

KBio2_004793

KBio2_005157

KBio2_007361

KBio3_000041

KBio3_000042

KBio3_001554

KBioGR_000021

KBioGR_001274

KBioSS_000021

KBioSS_002225

LS-137756

LS-190009

MFCD0006549

MFCD0006549; 1-Isobutoxy-2-pyrrolidino-3-(N-benzylanilino)propane hydrochloride

MFCD00868313

MolPort-005-935-595

N-Benzyl-N-(3-isobutoxy-2-(pyrrolidin-1-yl)propyl)aniline

N-benzyl-N-[3-(2-methylpropoxy)-2-(pyrrolidin-1-yl)propyl]aniline

N-Benzyl-N-[3-(2-methylpropoxy)-2-pyrrolidin-1-yl-propyl]aniline hydrochloride

N-benzyl-N-[3-(2-methylpropoxy)-2-pyrrolidin-1-ylpropyl]aniline

N-{3-[(2-methylpropyl)oxy]-2-pyrrolidin-1-ylpropyl}-N-(phenylmethyl)aniline

NCGC00015155-07

NCGC00162097-01

NCGC00162097-02

NCGC00162097-03

NCGC00162097-04

nchembio873-comp28

NINDS_000110

Org 5730

Org-5730

Prestwick0_000368

Prestwick1_000368

Prestwick2_000368

Prestwick3_000368

SPBio_000742

SPBio_002416

Spectrum2_000901

Spectrum3_000747

Spectrum4_000797

Spectrum5_000978

Spectrum_001745

Unicordium

USAN)

Vascor

Download: MOL2 SDF SMILES Flexibase

Annotations

Vendors

Physical Representations

Type pH range xlogP Des A‑Pol Apolar desolvation (kcal/mol) Des Pol Polar desolvation (kcal/mol) H Don H-bond donors H Acc H-bond acceptors Chg Net charge tPSA (Ų) MWT Molecular weight (g/mol) RB Rotatable bonds DL
Ref Reference (pH 7) 4.97 14.18 -37.61 1 3 1 17 367.557 10

Vendor Notes

Note Type Comments Provided By
ALOGPS_SOLUBILITY 6.55e-03 g/l DrugBank-approved
therap antiarrhythmic MicroSource Spectrum
Therapy Non-selective Ca2+ channel blocker which stimulates the binding of 1,4-dihydropyridine-based drugs to Ca2+ channels; ant SMDC MicroSource

Activity (Go SEA)

Clustered Target Annotations
Code Description Organism Class Affinity (nM) LE (kcal/mol/atom) Type
KCNH2-5-E HERG (cluster #5 Of 5), Eukaryotic Eukaryotes 6260 0.27 Binding ≤ 10μM
SCN1A-1-E Sodium Channel Protein Type I Alpha Subunit (cluster #1 Of 2), Eukaryotic Eukaryotes 840 0.32 Binding ≤ 10μM
SCN2A-1-E Sodium Channel Protein Type II Alpha Subunit (cluster #1 Of 2), Eukaryotic Eukaryotes 840 0.32 Binding ≤ 10μM
SCN3A-1-E Sodium Channel Protein Type III Alpha Subunit (cluster #1 Of 2), Eukaryotic Eukaryotes 840 0.32 Binding ≤ 10μM
SCN8A-1-E Sodium Channel Protein Type VIII Alpha Subunit (cluster #1 Of 2), Eukaryotic Eukaryotes 840 0.32 Binding ≤ 10μM
KCNH2-1-E HERG (cluster #1 Of 2), Eukaryotic Eukaryotes 550 0.32 Functional ≤ 10μM
LEF-1-B Anthrax Lethal Factor (cluster #1 Of 2), Bacterial Bacteria 4800 0.28 Binding ≤ 10μM
Z50425-3-O Plasmodium Falciparum (cluster #3 Of 22), Other Other 2500 0.29 Functional ≤ 10μM
ChEMBL Target Annotations
Uniprot Swissprot Description Affinity (nM) LE (kcal/mol/atom) Type
KCNH2_HUMAN Q12809 HERG, Human 184 0.35 Binding ≤ 1μM
SCN1A_HUMAN P35498 Sodium Channel Protein Type I Alpha Subunit, Human 840 0.32 Binding ≤ 1μM
SCN2A_HUMAN Q99250 Sodium Channel Protein Type II Alpha Subunit, Human 840 0.32 Binding ≤ 1μM
SCN3A_HUMAN Q9NY46 Sodium Channel Protein Type III Alpha Subunit, Human 840 0.32 Binding ≤ 1μM
SCN8A_HUMAN Q9UQD0 Sodium Channel Protein Type VIII Alpha Subunit, Human 840 0.32 Binding ≤ 1μM
LEF_BACAN P15917 Anthrax Lethal Factor, Bacan 4800 0.28 Binding ≤ 10μM
KCNH2_HUMAN Q12809 HERG, Human 184 0.35 Binding ≤ 10μM
SCN1A_HUMAN P35498 Sodium Channel Protein Type I Alpha Subunit, Human 840 0.32 Binding ≤ 10μM
SCN2A_HUMAN Q99250 Sodium Channel Protein Type II Alpha Subunit, Human 840 0.32 Binding ≤ 10μM
SCN3A_HUMAN Q9NY46 Sodium Channel Protein Type III Alpha Subunit, Human 840 0.32 Binding ≤ 10μM
SCN8A_HUMAN Q9UQD0 Sodium Channel Protein Type VIII Alpha Subunit, Human 840 0.32 Binding ≤ 10μM
KCNH2_HUMAN Q12809 HERG, Human 550 0.32 Functional ≤ 10μM
Z50425 Z50425 Plasmodium Falciparum 2500 0.29 Functional ≤ 10μM

Reactome Annotations from Targets (via Uniprot)

Description Species
Interaction between L1 and Ankyrins
Uptake and function of anthrax toxins
Voltage gated Potassium channels

Analogs ( Draw Identity 99% 90% 80% 70% )